Risk of HCC: genetic heterogeneity and complex genetics.

Hepatocellular carcinoma (HCC) is a common form of cancer that arises from hepatocytes and whose risk may be affected by several known environmental factors, including hepatitis viruses, alcohol, cigarette smoking, and others. Rare monogenic syndromes, such as alpha1-antitrypsin deficiency, glycogen storage disease type I, hemochromatosis, acute intermittent and cutanea tarda porphyria, as well as hereditary tyrosinemia type I are associated with a high risk of HCC. Several common conditions or diseases inherited as polygenic traits e.g. autoimmune hepatitis, type 2 diabetes, a family history of HCC, hypothyroidism, and non-alcoholic steatohepatitis also show an increased risk of HCC compared to the general population. Overall, the genetic susceptibility to HCC is characterized by a genetic heterogeneity; a high individual risk of HCC may thus be caused by several unlinked single gene defects, whose carriers are rare in the general population, or by more common conditions inherited by complex genetics.

[1]  A. Tamakoshi,et al.  Risk of death due to hepatocellular carcinoma among drinkers and ex-drinkers. Univariate analysis of JACC study data. , 2004, The Kurume medical journal.

[2]  Y. Liaw,et al.  Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study , 2009, European Journal of Human Genetics.

[3]  Lu-Yu Hwang,et al.  Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.

[4]  A. Pietrangelo Hereditary hemochromatosis--a new look at an old disease. , 2004, The New England journal of medicine.

[5]  C. Badenas,et al.  Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives , 2009, Clinical genetics.

[6]  N. Chalasani,et al.  Is Hypothyroidism a Risk Factor for Non-Alcoholic Steatohepatitis? , 2003, Journal of clinical gastroenterology.

[7]  P. Su,et al.  Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk of primary hepatocellular carcinoma in a Chinese population. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[8]  M. Badminton,et al.  Liver transplantation for porphyria: Who, when, and how? , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  M. Ziol,et al.  Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis , 2009, Hepatology.

[10]  R. Hultcrantz,et al.  Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. , 2003, Gastroenterology.

[11]  A. Tavill,et al.  Liver Disease in Alpha 1-Antitrypsin Deficiency: A Review , 2008, The American Journal of Gastroenterology.

[12]  E. Mayatepek,et al.  Molecular genetics of type 1 glycogen storage disease. , 2001, Molecular genetics and metabolism.

[13]  J. Faivre,et al.  Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. , 2000, Journal of hepatology.

[14]  H. Adami,et al.  Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma , 2000, International journal of cancer.

[15]  I. König,et al.  Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol‐associated cancer in heavy drinkers , 2006, International journal of cancer.

[16]  Manal M. Hassan,et al.  Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United States , 2009, Hepatology.

[17]  Philip J. Lee,et al.  Glycogen storage disease type I: pathophysiology of liver adenomas , 2002, European Journal of Pediatrics.

[18]  C. Wild,et al.  The toxicology of aflatoxins as a basis for public health decisions. , 2002, Mutagenesis.

[19]  M. Taniai,et al.  Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2009, Journal of Gastroenterology.

[20]  S. Sandberg,et al.  Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. , 2009, Clinical chemistry.

[21]  H. El‐Serag,et al.  Risk factors for the rising rates of primary liver cancer in the United States. , 2000, Archives of internal medicine.

[22]  L. Bianchi Glycogen storage disease I and hepatocellular tumours , 2005, European Journal of Pediatrics.

[23]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[24]  W. London,et al.  Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  F. Alvarez,et al.  Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. , 2009, World journal of gastroenterology.

[26]  K. Hemminki,et al.  Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden , 2003, Gut.

[27]  E. Taioli,et al.  Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. , 2001, Journal of hepatology.

[28]  Robert P. Clickner,et al.  Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). , 2007, Thyroid : official journal of the American Thyroid Association.

[29]  Tara L. Kieffer,et al.  Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .

[30]  J. Florez The Genetics of Type 2 Diabetes: A Realistic Appraisal in 2008 , 2008 .

[31]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  A. Green,et al.  Cancer and diabetes ‐ a follow‐up study of two populationbased cohorts of diabetic patients , 1997, Journal of internal medicine.

[33]  R. E. de Salamanca,et al.  ASSOCIATION OF PORPHYRIA CUTANEA TARDA AND PRIMARY LIVER CANCER: REPORT OF TEN CASES , 1982, The Journal of dermatology.

[34]  K. Kowdley,et al.  HFE-associated hereditary hemochromatosis , 2009, Genetics in Medicine.

[35]  C. Mize,et al.  The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. , 1976, The Journal of pediatrics.

[36]  V. Saudek,et al.  Acute intermittent porphyria – impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties , 2009, The FEBS journal.

[37]  V. Carreño,et al.  Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors. , 1985, Journal of hepatology.

[38]  D. Calvisi,et al.  Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. , 2006, Biochimica et biophysica acta.

[39]  K. Straif,et al.  Carcinogenicity of alcoholic beverages. , 2007, The Lancet. Oncology.

[40]  J. Gisbert,et al.  Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. , 2003, Journal of hepatology.

[41]  D. Frush,et al.  Hepatocellular carcinoma in glycogen storage disease type Ia: A case series , 2005, Journal of Inherited Metabolic Disease.

[42]  H. Adami,et al.  Excess risk of primary liver cancer in patients with diabetes mellitus. , 1996, Journal of the National Cancer Institute.

[43]  P. Schirmacher,et al.  Autocrine insulin‐like growth factor‐II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis , 2008, Hepatology.

[44]  T. Luedde,et al.  Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma , 2007 .

[45]  J. Haddow,et al.  Original Paper: Hereditary haemochromatosis and hepatocellular carcinoma in males: a strategy for estimating the potential for primary prevention , 2003 .

[46]  M. Gariboldi,et al.  Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. , 1994, Genomics.

[47]  A. Bergquist,et al.  Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients. , 2009, Journal of hepatology.

[48]  M. King,et al.  Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. , 1991, American journal of human genetics.

[49]  Shankar Subramaniam,et al.  Diet‐induced hepatocellular carcinoma in genetically‐predisposed mice , 2009, Human molecular genetics.

[50]  B. Zawirska,et al.  Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias. , 1983, Gastroenterology.

[51]  Katsutoshi Tokushige,et al.  Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C , 2009, Journal of gastroenterology and hepatology.

[52]  H. El‐Serag,et al.  Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. , 2008, American journal of epidemiology.

[53]  B. Bacon,et al.  Hereditary hemochromatosis in the post‐HFE era , 2008, Hepatology.

[54]  J. Leonard,et al.  Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I) , 2007, European Journal of Pediatrics.

[55]  E. Negri,et al.  Liver cirrhosis and the risk of primary liver cancer , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[56]  Fuchu He,et al.  Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case–control study in a high-risk region of China , 2006, Pharmacogenetics and genomics.

[57]  T. Luedde,et al.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.

[58]  D. Calvisi,et al.  Polygenic control of hepatocarcinogenesis in Copenhagen × F344 rats , 2004, International journal of cancer.

[59]  C. K. Hsiao,et al.  Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area , 2006, Oncogene.

[60]  M. Gariboldi,et al.  Chromosome mapping of murine susceptibility loci to liver carcinogenesis. , 1993, Cancer research.

[61]  H. Whittle,et al.  Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. , 2004, Pharmacogenetics.

[62]  M. McCarthy,et al.  Underlying genetic models of inheritance in established type 2 diabetes associations. , 2009, American journal of epidemiology.

[63]  T. Dragani,et al.  Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis. , 1986, Cancer letters.

[64]  D. Calvisi,et al.  Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10. , 1999, Cancer research.

[65]  T. Dragani,et al.  Genetic control of resistance to hepatocarcinogenesis by the mouse Hpcr3 locus , 2008, Hepatology.

[66]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[67]  S. Eriksson,et al.  Risk of hepatobiliary disease in adults with severe α1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? , 1996, European journal of gastroenterology & hepatology.

[68]  D. Harrison,et al.  Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis , 2000, Molecular pathology : MP.

[69]  D. García-Compeán,et al.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. , 2009, World journal of gastroenterology.

[70]  C. Scott The genetic tyrosinemias , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.

[71]  C. la Vecchia,et al.  Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy , 2006, Cancer Epidemiology Biomarkers & Prevention.

[72]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.